These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Biodistribution and internal dosimetry of the 188Re-labelled humanized monoclonal antibody anti-epidemal growth factor receptor, nimotuzumab, in the locoregional treatment of malignant gliomas. Torres LA; Coca MA; Batista JF; Casaco A; Lopez G; García I; Perera A; Peña Y; Hernández A; Sanchez Y; Romero S; Leyva R; Prats A; Fernandez R Nucl Med Commun; 2008 Jan; 29(1):66-75. PubMed ID: 18049099 [TBL] [Abstract][Full Text] [Related]
24. [Chronic gastrointestinal toxicity after external-beam radiation therapy for prostate cancer]. Sefrová J; Paluska P; Odrázka K; Jirkovský V Klin Onkol; 2009; 22(5):233-41. PubMed ID: 19886362 [TBL] [Abstract][Full Text] [Related]
25. Decreasing the adverse effects of cancer therapy: National Cancer Institute guidance for the clinical development of radiation injury mitigators. Movsas B; Vikram B; Hauer-Jensen M; Moulder JE; Basch E; Brown SL; Kachnic LA; Dicker AP; Coleman CN; Okunieff P Clin Cancer Res; 2011 Jan; 17(2):222-8. PubMed ID: 21047979 [TBL] [Abstract][Full Text] [Related]
26. Combining dosimetry for targeted radionuclide and external beam therapies using the biologically effective dose. Bodey RK; Flux GD; Evans PM Cancer Biother Radiopharm; 2003 Feb; 18(1):89-97. PubMed ID: 12667312 [TBL] [Abstract][Full Text] [Related]
27. Salvage prostate brachytherapy for localized prostate cancer failure after external beam radiation therapy. Lee HK; Adams MT; Motta J Brachytherapy; 2008; 7(1):17-21. PubMed ID: 18201939 [TBL] [Abstract][Full Text] [Related]
28. Physical models and simpler dosimetric descriptors of radiation late toxicity. Kong FM; Pan C; Eisbruch A; Ten Haken RK Semin Radiat Oncol; 2007 Apr; 17(2):108-20. PubMed ID: 17395041 [TBL] [Abstract][Full Text] [Related]
29. Further radiobiologic modeling of palliative radiotherapy: use of virtual trials. Jones B; Dale RG Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):221-9. PubMed ID: 17707276 [TBL] [Abstract][Full Text] [Related]
33. Optimize and refine therapeutic index in radiation therapy: Overview of a century. Chargari C; Magne N; Guy JB; Rancoule C; Levy A; Goodman KA; Deutsch E Cancer Treat Rev; 2016 Apr; 45():58-67. PubMed ID: 26986027 [TBL] [Abstract][Full Text] [Related]
34. Acute genitourinary toxicity after high dose rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: Second analysis to determine the correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity. Akimoto T; Katoh H; Noda SE; Ito K; Yamamoto T; Kashiwagi B; Nakano T Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):472-8. PubMed ID: 16168839 [TBL] [Abstract][Full Text] [Related]
35. New concepts for phase I trials: evaluating new drugs combined with radiation therapy. Deutsch E; Soria JC; Armand JP Nat Clin Pract Oncol; 2005 Sep; 2(9):456-65. PubMed ID: 16264990 [TBL] [Abstract][Full Text] [Related]
36. Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy. Vargas C; Martinez A; Kestin LL; Yan D; Grills I; Brabbins DS; Lockman DM; Liang J; Gustafson GS; Chen PY; Vicini FA; Wong JW Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1297-308. PubMed ID: 16029785 [TBL] [Abstract][Full Text] [Related]